Unless otherwise noted, all growth rates in this Release refer to same period in prior year.    2. Please see detailed guidance assumptions on page 7.    3. USD millions unless indicated otherwise.

The bill would permanently authorize and expand the Department of Veterans Affairs precision oncology program.

Telix Pharmaceuticals reported US$247 million in second-quarter revenue for the period ended 30 June 2026, providing a market ...

A noninvasive DNA blood test can identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are most ...

A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most likely to benefit ...

A negative scan does not always mean recurrent prostate cancer is nowhere to be found. Sometimes, the disease may simply be ...

A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most ...

U.S. Defense Secretary Pete Hegseth says the screenings will boost the military’s readiness and resilience, but doctors ...

A retired Utah radiologist shares his experience with robotic surgery after a prostate cancer diagnosis and encourages other men to get screened.

In the biggest venture capital financing this week, clinical-stage radiopharmaceutical AdvanCell has closed a $315 million ...

A prostate cancer treatment used by Jeremy Clarkson is as effective as surgery or radiotherapy but has fewer side effects, a ...

Clinicians report that early AKT inhibition side effects are manageable, allowing four out of five patients to maintain ...